
### [MONDO:0019349](http://purl.obolibrary.org/obo/MONDO_0019349)
**Label:** Sotos syndrome

**Subclasses:** [MONDO:0014951](http://purl.obolibrary.org/obo/MONDO_0014951) (Sotos syndrome 3; SOTOS3), [MONDO:0007299](http://purl.obolibrary.org/obo/MONDO_0007299) (Sotos syndrome 1), [MONDO:0013885](http://purl.obolibrary.org/obo/MONDO_0013885) (Malan overgrowth syndrome), 

**Mapped go classes:** [GO:0016569](http://purl.obolibrary.org/obo/GO_0016569) (covalent chromatin modification), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0046975](http://purl.obolibrary.org/obo/GO_0046975) (histone methyltransferase activity (H3-K36 specific)), [GO:0000414](http://purl.obolibrary.org/obo/GO_0000414) (regulation of histone H3-K36 methylation), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0042974](http://purl.obolibrary.org/obo/GO_0042974) (retinoic acid receptor binding), [GO:0021680](http://purl.obolibrary.org/obo/GO_0021680) (cerebellar Purkinje cell layer development), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001702](http://purl.obolibrary.org/obo/GO_0001702) (gastrulation with mouth forming second), [GO:0016571](http://purl.obolibrary.org/obo/GO_0016571) (histone methylation), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0033135](http://purl.obolibrary.org/obo/GO_0033135) (regulation of peptidyl-serine phosphorylation), [GO:0021707](http://purl.obolibrary.org/obo/GO_0021707) (cerebellar granule cell differentiation), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0005881](http://purl.obolibrary.org/obo/GO_0005881) (cytoplasmic microtubule), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0050681](http://purl.obolibrary.org/obo/GO_0050681) (androgen receptor binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0018024](http://purl.obolibrary.org/obo/GO_0018024) (histone-lysine N-methyltransferase activity), [GO:0030178](http://purl.obolibrary.org/obo/GO_0030178) (negative regulation of Wnt signaling pathway), [GO:0030331](http://purl.obolibrary.org/obo/GO_0030331) (estrogen receptor binding), [GO:0031941](http://purl.obolibrary.org/obo/GO_0031941) (filamentous actin), [GO:1903025](http://purl.obolibrary.org/obo/GO_1903025) (regulation of RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0006260](http://purl.obolibrary.org/obo/GO_0006260) (DNA replication), [GO:0008168](http://purl.obolibrary.org/obo/GO_0008168) (methyltransferase activity), [GO:0005694](http://purl.obolibrary.org/obo/GO_0005694) (chromosome), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0042799](http://purl.obolibrary.org/obo/GO_0042799) (histone methyltransferase activity (H4-K20 specific)), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0048741](http://purl.obolibrary.org/obo/GO_0048741) (skeletal muscle fiber development), [GO:0048708](http://purl.obolibrary.org/obo/GO_0048708) (astrocyte differentiation), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0035097](http://purl.obolibrary.org/obo/GO_0035097) (histone methyltransferase complex), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0046965](http://purl.obolibrary.org/obo/GO_0046965) (retinoid X receptor binding), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0008017](http://purl.obolibrary.org/obo/GO_0008017) (microtubule binding), [GO:0046966](http://purl.obolibrary.org/obo/GO_0046966) (thyroid hormone receptor binding), [GO:0090090](http://purl.obolibrary.org/obo/GO_0090090) (negative regulation of canonical Wnt signaling pathway), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development), [GO:0042054](http://purl.obolibrary.org/obo/GO_0042054) (histone methyltransferase activity), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0032259](http://purl.obolibrary.org/obo/GO_0032259) (methylation), 

**Class expressions from DL-Learner:**

- [GO:0035258](http://purl.obolibrary.org/obo/GO_0035258) (steroid hormone receptor binding) 56.25%
- [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding) 53.32%
- [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 53.32%
- [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 53.32%
- [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 53.32%
- [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 53.32%
- [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 53.32%
- [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 53.32%
- [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 53.32%
- [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 53.32%
- [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 53.32%
- [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 53.32%
- [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2000745](http://purl.obolibrary.org/obo/GO_2000745) (obsolete positive regulation of transcription from RNA polymerase III promoter involved in smooth muscle cell differentiation)) 53.32%
- [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2000695](http://purl.obolibrary.org/obo/GO_2000695) (null)) 53.32%
- [GO:0035257](http://purl.obolibrary.org/obo/GO_0035257) (nuclear hormone receptor binding) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2000602](http://purl.obolibrary.org/obo/GO_2000602) (obsolete regulation of interphase of mitotic cell cycle)) 53.32%


